|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|
| Operating activities | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||||
| Depreciation and amortization | ||||
| Stock-based compensation | ||||
| Charitable donation of Class A common stock | ||||
| Provision for expected credit losses | ||||
| Change in fair value of warrants | ||||
| Non-cash lease expense | ||||
| Deferred income tax benefit | ||||
| Loss on disposal of assets | ||||
| Non-cash impairment charges | ||||
| Other non-cash operating activities, net | ||||
| Changes in operating assets and liabilities: | ||||
| Accounts receivable | ||||
| Contract assets | ||||
| Prepaid expenses and other current and noncurrent assets | ||||
| Deferred contract costs | ||||
| Accounts payable | ||||
| Accrued expenses and other current liabilities | ||||
| Operating lease liabilities | ||||
| Unearned revenue | ||||
| Other liabilities, noncurrent | ||||
| Net cash provided by (used in) operating activities | ||||
| Investing activities | ||||
| Purchases of property and equipment | ||||
| Capitalized internal-use software | ||||
| Acquisitions, net of cash acquired | ||||
| Purchases of investments | ||||
| Sales and maturities of investments | ||||
| Net cash used in investing activities | ||||
| Financing activities | ||||
| Proceeds from issuance of Class A common stock upon initial public offering, net of underwriting discounts | ||||
| Cash received for employee payroll tax withholdings | ||||
| Cash paid for employee payroll tax withholdings | ||||
| Surrender of common stock for withholding tax purposes | ||||
| Proceeds from line of credit | ||||
| Repayment of line of credit | ||||
| Proceeds from exercise of warrants | ||||
| Payment of deferred finance costs | ||||
| Payment of deferred offering costs | ||||
| Proceeds from exercise of stock options and purchases under the employee stock purchase plan | ||||
| Repurchase of common stock | ||||
| Proceeds from issuance of preferred stock | ||||
| Costs incurred from issuance of preferred stock | ||||
| Net cash used in financing activities | ||||
| Net increase (decrease) in cash and cash equivalents | ||||
| Cash and cash equivalents, beginning of year | ||||
| Cash and cash equivalents, end of year | ||||
| Supplemental disclosure of cash flow information | ||||
| Cash paid for income taxes, net | ||||
| Cash paid for interest | ||||
| Cash received for early exercise of stock options | ||||
| Supplemental disclosure of non-cash investing and financing activities | ||||
| Right-of-use assets obtained in exchange for new operating lease liabilities | ||||
| Capitalization of stock-based compensation for internal-use software | ||||
| Vesting of early exercised stock options | ||||
| Employee receivables for options exercised | ||||
| Purchase of property and equipment | ||||
| Common stock issued in connection with acquisition | ||||
| Fair value of substituted stock options granted in connection with acquisition | ||||
| Accrued offering costs | ||||
| Accretion of redeemable convertible preferred stock to redemption value | ||||
Loading...